Table 1 Evaluation of K562... | American Society of Hematology

Table 1

Evaluation of K562 micrometastasis

	Mice with micrometastasis, no. (%)	Total metastasis- positive organs, no. (%)
Control	14/19 (73)	46/72 (63)*
UCB-NK	7/13 (53)	10/48 (20)
hESC-NK	1/13 (7)†	1/36 (3)

	Mice with micrometastasis, no. (%)	Total metastasis- positive organs, no. (%)
Control	14/19 (73)	46/72 (63)*
UCB-NK	7/13 (53)	10/48 (20)
hESC-NK	1/13 (7)†	1/36 (3)

The presence of micrometastasis was evaluated macroscopically by detection of luc⁺ foci after bioluminescent imaging.

P < .05 versus control versus UCB-NK and hESC-NK by z test of proportions.

P < .05 for hESC-NK versus control and UCB-NK by z test of proportions.